Hello everyone! Today i want to share some earning reports with you!1. $Roper(ROP)$ announced earnings this morning, here's a glimpse from their presentation. What are your thoughts?Image2.Lots of earnings this week!! $Domino's Pizza(DPZ)$ $Waste Management(WM)$ $SoFi Technologies Inc.(SOFI)$ $Visa(V)$ $United Parcel Service Inc(UPS)$ $Roper(ROP)$ $Microsoft(MSFT)$ $Humana(HUM)$ $M

Pfizer (PFE) is gearing up to release its earnings on April 29th, just before the market opens. As one of the most influential players in the global healthcare landscape, the company’s performance is always under scrutiny, and personally, I’m excited to see what numbers they bring to the table. But this is just my personal opinion, and I’m feeling optimistic about Pfizer's future. Looking at the stock’s 52-week range, which has fluctuated between $20.92 and $31.54, Pfizer’s current price of around $23 is well off its high. While this might seem like a setback, it could actually present a golden opportunity for investors seeking value. The company has been through some ups and downs, but it remains a formidable force in the pharmaceutical world—especially after its ground-breaking collabora

Apple Inc. ( $Apple(AAPL)$ AAPL) is scheduled to report its fiscal second-quarter earnings on Thursday, May 1, 2025, after the market closes. Analysts anticipate earnings per share (EPS) of approximately $1.60 for the quarter ending March 2025, reflecting a modest increase from the $1.53 reported in the same quarter last year. Technical Analysis of $Apple(AAPL)$ As of the latest close, AAPL is trading at $209.28. The stock remains below a key moving average resistance level, indicating that upward momentum may be limited in the near term.​ Resistance: The area between $210 and $217 serves as a resistance zone, corresponding to a previous price gap. This gap may act as a barrier to upward movement unless s

Let’s check out the top movers after earnings!1. $Procter & Gamble(PG)$ fell nearly 5% after releasing its earnings report, ultimately closing down 3.74%.EPS: $1.54 vs. $1.53 expected (Beat +0.65%)Revenue: $19.78 billion vs. $20.11 billion expected (Miss -1.64%)Cut outlook: Now expecting flat sales growth for fiscal 2025, down from the prior forecast of 2%–4% revenue growth. Also reduced its core EPS guidance to $6.72–$6.82, down from the previous outlook of $6.91–$7.05.The company warned it would have to raise prices to offset higher tariff costs and lowered its annual forecast. Net sales fell in Q3 due to a “challenging and volatile consumer and geopolitical environment,” with some business segments underperforming. U.S. consumer spending also